Sensei Biotherapeutics Inc (SNSE) stock is lower by -85.27% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SNSE stock a score of 35 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. SNSE’s rank also includes a long-term technical score of 5.
What’s Happening with SNSE Stock Today
Sensei Biotherapeutics Inc (SNSE) stock is up 4.97% while the S&P 500 is lower by -0.38% as of 11:57 AM on Tuesday, May 31. SNSE has gained $0.09 from the previous closing price of $1.81 on volume of 40,978 shares. Over the past year the S&P 500 is lower by -1.42% while SNSE is lower by -85.27%. SNSE lost -$1.35 per share in the over the last 12 months. Click Here to get the full Stock Report for Sensei Biotherapeutics Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.